Multidisciplinary management of chronic refractory pain in autosomal dominant polycystic kidney disease

Author:

van Luijk Franka1,Gansevoort Ron T1,Blokzijl Hans2,Groen Gerbrand J3,de Haas Robbert J4,Leliveld Anna M5,Meijer Esther1,Perdok Joke M3,Stellema Ruud3,Wolff Andreas P3,Casteleijn Niek F5

Affiliation:

1. Department of Nephrology, University Medical Center Groningen, University of Groningen , Groningen , The Netherlands

2. Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen , Groningen , The Netherlands

3. Department of Anesthesiology (Pain Center), University Medical Center Groningen, University of Groningen , Groningen , The Netherlands

4. Department of Radiology, University Medical Center Groningen, University of Groningen , Groningen , The Netherlands

5. Department of Urology, University Medical Center Groningen, University of Groningen , Groningen , The Netherlands

Abstract

ABSTRACT Background Chronic pain is often difficult to manage in autosomal dominant polycystic kidney disease (ADPKD) patients and sometimes even leads to nephrectomy. We analyzed the long-term efficacy of our innovative multidisciplinary protocol to treat chronic refractory pain that aims to preserve kidney function by applying among other sequential nerve blocks. Methods Patients were eligible if pain was present ≥3 months with a score of ≥50 on a visual analog scale (VAS) of 100, was negatively affecting quality of life and if there had been insufficient response to previous therapies, including opioid treatment. Treatment options were, in order, analgesics, cyst aspiration and fenestration, nerve blocks and nephrectomy. Results A total of 101 patients were assessed in our clinic (mean age 50 ± 11 years, 65.3% females). Eight patients were treated with medication, 6 by cyst aspiration or fenestration, 63 by nerve blocks and 6 received surgery as the first treatment option. Overall, 76.9% experienced a positive effect on pain complaints shortly after treatment. The VAS score was reduced from 60/100 to 20/100 (P < 0.001) and patients decreased their number of nonopioid and opioid analgesics significantly (P < 0.001, P = 0.01, respectively). A substantial number of the patients (n = 51) needed additional treatment. At the end of follow-up in only 13 patients (12.9%) was surgical intervention necessary: 11 nephrectomies (of which 10 were in patients already on kidney function replacement treatment), 1 liver transplantation and 1 partial hepatectomy. After a median follow-up of 4.5 years (interquartile range 2.5–5.3), 69.0% of the patients still had fewer pain complaints. Conclusions These data indicate that our multidisciplinary treatment protocol appears effective in reducing pain in the majority of patients with chronic refractory pain, while postponing or even avoiding in most patients surgical interventions such as nephrectomy in most patients.

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Reference26 articles.

1. Pain patterns in patients with polycystic kidney disease;Bajwa;Kidney Int,2004

2. Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1–4: a cross-sectional study;Miskulin;Am J Kidney Dis,2014

3. Autosomal dominant polycystic kidney disease;Torres;Lancet,2007

4. Tolvaptan in patients with autosomal dominant polycystic kidney disease;Torres;N Engl J Med,2012

5. Development of the autosomal dominant polycystic kidney disease impact scale: a new health-related quality-of-Life instrument;Oberdhan;Am J Kidney Dis,2018

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3